Episode 10: How Biosimilars Could Impact the Future of Cancer Care 

Rowena Schwartz, PharmD, BCOP, associate professor of pharmacy at the University of Cincinnati, joins Deborah Struth, MSN, RN, ONS research associate, to discuss the rapid emergence of biosimilar products on the market and how they’ll impact the treatment of cancer. Learn more about what biosimilars are, their approval processes, and the important things to know for practice. 

Episode Notes:

Listen on:

Listen on iTunes, Listen on the Google Play Store, Listen on Stitcher, Listen on Spotify

ONS Podcasts

Expand your knowledge by listening to the Oncology Nursing Podcast.

View All Podcasts

Related Topics